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A GOOD SCORE?:  EXAMINING TWENTY 
YEARS OF DRUG COURTS IN THE UNITED 
STATES AND ABROAD 
Kimberly Y.W. Holst 
I.  INTRODUCTION:  WHAT‘S THE CURRENT STATE OF DRUG COURTS IN THE 
UNITED STATES AND AROUND THE WORLD? 
In 2009, we saw the passing of the twentieth anniversary of drug 
courts1 in the United States.2  This timing presents an opportune moment 
to review the state of drug courts in the United States and the 
development of drug courts internationally.  While the United States has 
                                                 
 Legal Writing Faculty, Hamline University School of Law.  Professor Holst would like 
to thank Morgan Bianco, J.D. and Megan Jens, J.D., M.L.I.S. for their excellent research 
assistance.  She would also like to thank the Legal Writing Institute‘s Writers Workshop for 
providing feedback and support on this article and on how to complete this type of work 
within a Legal Writing professor‘s schedule. 
1 Drug courts as used in this article refers to the drug treatment court model.  There are 
several other types of drug courts used throughout the United States and the world 
including juvenile drug courts, family drug courts, and re-entry drug courts.  Additionally, 
this paper does not address concerns of constitutionality, collaboration, judicial discretion, 
and similar concerns in the context of drug courts.  See Peggy Fulton Hora & Theodore 
Stalcup, Drug Treatment Courts in the Twenty-First Century:  The Evolution of The Revolution in 
Problem-Solving Courts, 42 GA. L. REV. 717 (2008) (discussing the many concerns that arise in 
the context of drug treatment courts); Peggy Fulton Hora, William G. Schma & John T.A. 
Rosenthal, Therapeutic Jurisprudence and the Drug Treatment Court Movement:  Revolutionizing 
the Criminal Justice System’s Response to Drug Abuse and Crime in America, 74 NOTRE DAME L. 
REV. 439, 516–28 (1999) (discussing various concerns arising in drug courts). 
2 Morris B. Hoffman, Commentary, The Drug Court Scandal, 78 N.C. L. REV. 1437, 1461 
(June 2000).  New York City is credited with using a separate court to deal with drug cases 
(Narcotics Courts) in the 1970‘s.  Id. at 1460.  These courts were focused on managing the 
number of drug cases that were being introduced and not on treatment and by the 1980‘s 
these courts had taken on so many non-drug cases they had basically become traditional 
courts.  Id.  In the late 1980‘s, these courts were reconfigured and named ―N Parts‖ and 
again were focused on dealing with the sheer number of drug cases in a traditional 
manner.  Id. at 1460–61.  See also Steven Belenko, Research on Drug Courts:  A Critical Review, 
1 NAT‘L DRUG CT. INST. REV. 1, 4 (1998) (discussing the birth of ―Narcotics Courts‖ in New 
York); Dwight Vick & Jennifer Lamb Keating, Community-Based Drug Courts:  Empirical 
Success.  Will South Dakota Follow Suit?, 52 S.D. L. REV. 288, 288–90 (2007) (reviewing a 
history of drug courts).  The first drug court with a focus on treatment was established in 
Dade County, Miami, Florida in 1989.  Hoffman, supra, at 1461; see also STEVEN BELENKO & 
TAMARA DUMANOVSKY, BUREAU OF JUSTICE ASSISTANCE, U.S. DEP‘T OF JUSTICE, Pub. No. 
NCJ-144531, SPECIAL DRUG COURTS:  PROGRAM BRIEF 4 (1993); Michael C. Dorf & Jeffrey A. 
Fagan, Foreword, Community Courts and Community Justice:  Problem-Solving Courts:  From 
Innovation to Institutionalization, 40 AM. CRIM. L. REV. 1501, 1502–03 (2003); John S. 
Goldkamp, The Drug Court Response:  Issues and Implications for Justice Change, 63 ALB. L. 
REV. 923, 923 (2000); Vick, supra, at 290; Michael Wright, Reversing the Prison Landscape:  The 
Role of Drug Courts in Reducing Minority Incarceration, 8 RUTGERS RACE & L. REV. 79, 88–89 
(2006). 
Holst: A Good Score?:  Examining Twenty Years of Drug Courts in the Unit
Produced by The Berkeley Electronic Press, 2010
74 VALPARAISO UNIVERSITY LAW REVIEW [Vol. 45 
served as a model and a leader in the creation and development of drug 
courts, countries all over the world have tweaked the United States‘ 
model and have altered the landscape in the structure and development 
of drug courts. 
Part II of this Article briefly discusses the development and current 
status of drug courts in the United States.  Part III examines a sampling 
of drug courts from around the world.  Next, the article takes a look at 
some of the core principles in drug treatment.  The final section discusses 
possible changes to the United States‘ system of drug courts based on 
lessons learned from its international counterparts and from the 
principles of drug treatment. 
II.  DRUG COURTS IN THE UNITED STATES 
Over 1,200 counties in the United States operate a drug court or are 
planning to establish a drug court.3  Drug courts have been implemented 
or are planned in all fifty states plus the District of Columbia, Northern 
Marina Islands, Puerto Rico, and Guam.4  Additionally, there are 111 
tribal drug court programs.5  Based on these numbers, it is clear that 
communities and legal systems have put their faith, if not their stamp of 
approval, in drug courts.6 
The treatment-focused drug court that is popular today developed in 
Dade County, Florida in 1989.7  This court began in response to the 
astonishingly large number of offenders with drug-related crimes.8  The 
thought was that treatment or rehabilitation would serve as a way to 
help deal with problems relating to substance abuse and reduce 
recidivism.9  What resulted is an explosion of drug treatment courts in 
                                                 
3 BJA DRUG COURT CLEARINGHOUSE PROJECT, SUMMARY OF DRUG COURT ACTIVITY BY 
STATE AND COUNTY 139 (July 14, 2009), available at http://www1.spa.american.edu/ 
justice/documents/2150.pdf.  There are 3155 counties in the United States and 1416 have or 
have plans for a drug court.  This is roughly forty-five percent of the counties in the United 
States.  Id. 
4 Id. 
5 Id.  For the tribal drug courts, seventy-six have been implemented and thirty-five are 
in the planning stages.  Id. 
6 See, e.g., Trent Oram & Kara Gleckker, Comment, An Analysis of the Constitutional 
Issues Implicated in Drug Courts, 42 IDAHO L. REV. 471, 478 (2006) (―Although it is difficult to 
exactly measure the success and effects of drug courts, drug court is generally accepted as a 
worthwhile and beneficial program.‖). 
7 BELENKO & DUMANOVSKY, supra note 2, at 4. 
8  Vick, supra note 2, at 289. 
9 Id. 
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the United States and in the world.  It has even been termed ―the most 
significant criminal justice initiative in the last century.‖10 
While some early drug courts were viewed merely as a means of 
quickly and efficiently dispatching of the growing number of drug cases 
in the courts,11 this expedited model is not the model of drug courts that 
stuck in the United States.12  The judiciary determined that while 
expeditious case management was a goal of the drug court system, if 
nothing was done to stymie the rising number of cases relating to drug 
abuse, no expedited process would be sufficient to manage the excessive 
caseloads.13  Instead, the courts turned to a more therapeutic form of case 
management in developing the drug treatment courts.14 
These drug courts focused on the treatment of the defendant‘s drug 
abuse rather than the simple punishment and processing of the 
defendant through the criminal justice system.15  An important 
distinguishing component of these drug courts is the adoption of the 
view that addiction is a disease that requires treatment.16  The goal then 
is to reduce judicial caseloads by ―decreasing recidivism and possibly the 
number of drug-related arrests in general.‖17  As such, these drug courts 
necessarily approach the issues related to drug abuse as conditions 
requiring therapeutic treatment.18 
There are a staggering number of incarcerated adults who have 
alcohol or drug abuse issues.19  Some estimates put costs associated with 
this issue in the range of ―upwards of $12.9 billion per year [spent] on 
illicit drug control, including police protection, the judiciary, corrections, 
and related costs.‖20  The extreme number of offenders with drug abuse 
problems and the increasing costs related to the offenders and offenses 
ensure that some system of treating drug crimes will remain a part of the 
United States judicial system in the present and in the foreseeable future. 
                                                 
10 Id. at 291 (quoting C. West Huddleson III et al., Painting the Current Picture: A National 
Report on Drug Courts and Other Problem Solving Court Programs in the United States, 1 NAT‘L 
DRUG CT. INST. REV. 1, 1 (2004)). 
11 Hora, Schma & Rosenthal, supra note 1, at 462–63.  Some expedited drug case 
management courts still exist and use standard means of punishment—probation, parole—
for drug offenders.  Id. at 463. 
12 Id. at 425. 
13 Id. at 463. 
14 Id. 
15 Id. 
16 Id. 
17 Id. 
18 Id. 
19 Hora & Stalcup, supra note 1, at 720.  The total impact on society attributable to alcohol 
and drug use was in excess of $180 billion in 2002.  Id. at 721. 
20 Id.  These offenders also impact the cost of emergency room visits.  Id. 
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The development of drug courts in the United States has not been 
without its opponents.21  Some argue that drug courts were developed as 
a compromise within the therapeutic community seeking a method 
focused on treatment rather than culpability.22  Additionally, for the 
courts, it presented a method to expedite case processing, requirement of 
treatment, retention of traditional forms of incapacitation for failing 
participants, and it avoided calls for more radical legislative change.23  
Although this is a more cynical view, it does not contradict the following 
purposes indicated by drug court proponents:  addressing the 
overloaded criminal courts, emphasizing therapeutic approaches to treat 
addiction, reducing high expenditures resulting from the war on drugs, 
providing an alternative team-focused model of criminal court, 
establishing links to restorative justice, and dealing with heavy-handed 
mandatory sentencing guidelines.24 
Drug courts receive their authority via a state rule or statute.  Since 
their development in 1989, there has been an increasing focus on creating 
standards for efficiently and effectively operating drug courts.  This is 
evident by the creation of organizations such as the National Association 
of Drug Court Professionals (―NADCP‖),25 the National Drug Court 
Institute (―NDCI‖),26 the Congress of State Drug Court Associations,27 
                                                 
21 Josh Bowers, Contraindicated Drug Courts, 55 UCLA L. REV. 783, 795–96 (2008). 
22 Id. 
23  Id. 
24 Candace McCoy, Commentary, Community Courts and Community Justice:  The Politics 
of Problem-Solving:  An Overview of the Origins and Development of Therapeutic Courts, 40 AM. 
CRIM. L. REV. 1513, 1518 ( 2003). 
25 About NADCP, NAT‘L ASS‘N OF DRUG CT. PROFS., http://www.nadcp.org/learn/about 
-nadcp (last visited Oct. 10, 2010).  The NADCP focuses on reducing substance abuse, crime 
and recidivism by promoting and advocating for the establishment and funding of Drug 
Courts and providing for collection and dissemination of information, technical assistance, 
and mutual support to association members.  Id. 
26 NAT‘L DRUG CT. INST., http://www.ndci.org/ndci-home/ (last visited Oct. 10, 2010).  
The NDCI is  a partner organization of the NADCP.  Id.  It was established in 1997 and  
is supported by the White House Office of National Drug Control 
Policy; U.S. Department of Justice, Office of Justice Programs through 
the Bureau of Justice Assistance, Office of Juvenile Justice & 
Delinquency Prevention, and the National Institute of Justice; U.S. 
Department of Health & Human Services, Substance Abuse & Mental 
Health Services Administration through the Center for Substance 
Abuse Treatment; and the State Justice Institute.  
 Id.  The mission of the NDCI is to support education, research, and scholarship for drug 
court and other court-based intervention programs.  About NDCI, NAT‘L DRUG CT. INST., 
http://www.ndci.org/trainings/about-ndci (last visited Oct. 10, 2010). 
27 Congress of State Drug Court Associations, NAT‘L ASS‘N OF DRUG CT. PROFS., 
http://www.nadcp.org/act/policy-action-center/congress-state-drug-court-associations 
(last visited Oct. 10, 2010).  The Congress of State Drug Court Programs is also a division of 
the NADCP.  Id.  ―The Congress of State Drug Court Association (CSDCA) was formed in 
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and the Office of Drug Court Programs within the Office of Justice 
Programs (―OJP‖) in the U.S. Department of Justice.28  One significant 
example of such standards is the Ten Key Components issued by the 
Bureau of Justice Assistance of the Office of Justice Programs, U.S. 
Department of Justice.  The Ten Key Components are as follows: 
Key Component #1:  Drug courts integrate alcohol and 
other drug treatment services with justice system case 
processing. 
 
Key Component #2:  Using a nonadversarial approach, 
prosecution and defense counsel promote public safety 
while protecting participants‘ due process rights. 
 
Key Component #3:  Eligible participants are identified 
early and promptly placed in the drug court program. 
 
Key Component #4:  Drug courts provide access to a 
continuum of alcohol, drug, and other related treatment 
and rehabilitation services. 
 
Key Component #5:  Abstinence is monitored by 
frequent alcohol and other drug testing. 
 
Key Component #6:  A coordinated strategy governs 
drug court responses to participants‘ compliance. 
 
Key Component #7:  Ongoing judicial interaction with 
each drug court participant is essential. 
 
Key Component #8:  Monitoring and evaluation 
measure the achievement of program goals and gauge 
effectiveness. 
                                                                                                             
1997 by NADCP to bring together state Drug Court Associations to assist in the 
development of the national agenda for the Drug Court movement.‖  Id.   ―Since that time, 
the CSDCA has become the advocacy voice for Drug Court professionals.  With over 30 
states having their own association and serving on the CSDCA, the CSDCA plays in [sic] 
integral role at both the state and federal level . . . .‖  Id. 
28 Looking at a Decade of Drug Courts, NAT‘L CRIMINAL JUSTICE REFERENCE SERV., 
http://www.ncjrs.gov/html/bja/decade98.htm (last visited Sept. 24, 2010) [hereinafter 
Decade of Drug Courts].  The Drug Court Clearinghouse Technical Assistance Project 
(―DCCTAP‖) ―compiles operational and evaluative information on adult, juvenile and 
family drug court programs throughout the United States.‖  Id. 
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Key Component #9:  Continuing interdisciplinary 
education promotes effective drug court planning, 
implementation, and operations. 
 
Key Component #10:  Forging partnerships among drug 
courts, public agencies, and community-based 
organizations generates local support and enhances 
drug court program effectiveness.29 
The focus of the Key Components is on a non-adversarial, treatment-
based approach to handling cases dealing with drug offenders.  The 
offender has direct and frequent interaction with the treatment team 
which includes interaction with the judge.  The offender is continuously 
monitored and assisted by treatment professionals as well as the court.30  
It is important to note that abstinence from drug use is a key component 
of drug courts in the United States.  Additionally, the key components 
recognize the need to view the issues of the drug abuser in the larger 
picture of the legal system.  However, notably absent from the key 
components is the articulated need to view the drug abuser herself in a 
more holistic context—addressing the larger problems facing the drug 
abuser that impact her use and recovery.31 
―The core components of a drug court typically include regular 
status hearings in court, random weekly urinalyses, mandatory 
completion of a prescribed regimen of substance abuse treatment, 
progressive negative sanctions for program infractions, and rewards for 
program accomplishments.‖32  While abstinence is a key component of 
most drug court treatment programs, a single finding of drug use will 
not typically result in expulsion from the program.33  Instead, 
                                                 
29 BUREAU OF JUSTICE ASSISTANCE, NCJ 205621, DEFINING DRUG COURTS:  THE KEY 
COMPONENTS iii (1997), available at http://www.ojp.usdoj.gov/BJA/grant/DrugCourts/ 
DefiningDC.pdf [hereinafter THE KEY COMPONENTS]; see also Hora & Stalcup, supra note 1, 
at 725. 
30 THE KEY COMPONENTS, supra note 29, at iii. 
31 Key component #4 suggests access to a variety of services, but does not state that 
support will be provided to obtain and follow through with these services.  Key component 
#10 suggests that the courts will partner with other agencies.  Again, the focus is on the 
courts working with other agencies to run the program, rather than on the participant and 
her use or support through these other agencies.  Key component #9 suggests 
interdisciplinary education for the court, not the participants. 
32 Douglas B. Marlowe, Integrating Substance Abuse Treatment and Criminal Justice 
Supervision, SCI. & PRAC. PERSP. 4, 7 (August 2003); see also Hora & Stalcup, supra note 1, at 
726–27. 
33 Hora & Stalcup, supra note 1, at 762. 
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participants may be subjected to brief periods of incarceration for failure 
to comply.34 
The judge in a drug court takes on a more proactive role by not only 
presiding over the legal and procedural issues presented but also serving 
as an enforcer of positive offender behavior.35  While the judge takes a 
central role, the team-based approach is essential to the functioning of 
the drug court.36  The team typically consists of prosecutors, defense 
attorneys, and drug treatment professionals working together to assist 
the drug offender in overcoming their drug problems and related issues, 
such as finances, employment, and related issues.37  Offenders who 
successfully complete the program may have their charges dismissed (in 
a diversion or deferred prosecution model) or have their probation 
period reduced or sentence suspended or deferred (in a post-
adjudication model).38 
In theory, this approach is therapeutic and aimed at treating the 
cause of the offender‘s behavior as opposed to punishing the offender for 
his or her behavior.  In reality, the effectiveness of these programs at 
providing appropriate treatment, protecting individual rights, and 
reducing recidivism has come under fire.  The problem is that hard data 
on drug courts is hard to come by for a number of reasons including 
difficulty in determining control and target groups that provide accurate 
comparisons, difficulty in determining an impact to be measured, and 
differences in drug court practices and standards across the United 
States.39  As a result, the available data, arguably, does not conclusively 
support or discount the success of drug courts.40 
                                                 
34 Id. 
35 Justine Walker, International Experience of Drug Courts, SCOTTISH EXEC. CENT. 
RESEARCH UNIT (2001), available at http://www.scotland.gov.uk/Resource/Doc/156630/ 
0042081.pdf. 
36 Id. 
37 Id. 
38 Oram, supra note 6, at 478; U.S. GOV‘T ACCOUNTABILITY OFFICE, GAO-05-219, ADULT 
DRUG COURTS:  EVIDENCE INDICATES RECIDIVISM REDUCTIONS AND MIXED RESULTS FOR 
OTHER OUTCOMES 36 (2005), available at http://www.gao.gov/new.items/d05219.pdf.  
There are a variety of methods and reasons for adopting one model over the other (in terms 
of timing entrance into the drug court program).  It is important to note that pre-plea 
programs get individuals into treatment faster than post-plea adjudication programs.  Hora 
& Stalcup, supra note 1, at 785–86. 
39 Hoffman, supra note 2, at 1480. 
40 Pamela M. Casey & David B. Rottman, Problem-Solving Courts:  Models and Trends, 26 
JUST. SYS. J. 35, 45 (2005).  ―[T]he lack of scientific rigor‖ used in studies for drug courts (i.e. 
reduction in jail costs, recidivism rates, retention, graduation) allows for ―proponents and 
skeptics to find data in support of their positions.‖  Id.  See also Hora, Schma & Rosenthal, 
supra note 1, at 516–28.  Skeptics of the drug court model cite a number of different reasons 
for changing or eliminating the use of drug courts in the criminal justice system.  Some of 
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One of the central arguments against drug courts from a treatment 
standpoint is that a drug court holds itself out as a therapeutic 
alternative for addressing drug offenders while using traditional 
punitive measures to ―treat‖ failures within the drug court system.41  
During the treatment phase, the drug user is treated as a sick patient 
with crimes serving as the symptoms of his illness.42  However, when the 
participant fails to respond to treatment, his crimes are not treated as 
symptoms; they convert back to the traditional paradigm of a willfully 
committed crime for which punishment is doled out accordingly.43  This 
schizophrenic view of the nature of drug offenses causes internal discord 
in the process and difficulty for those engaged within the process.44 
                                                                                                             
the more common concerns deal with the mixed and often confusing role of drug courts as 
a mode of therapy, but enforced with traditional punitive techniques for failures, 
safeguarding the rights of participants throughout the drug court process, and the 
requirement of judges and defense attorneys to assume non-traditional and arguably 
contradictory roles throughout the process.  See, e.g., Hora, Schma & Rosenthal, supra note 
1, at 508–35.  Additionally, drug court statistics are frequently cited as being biased or 
incomplete, allowing for easy manipulation to suit proponents‘ purposes.  See, e.g., Casey, 
supra note 40, at 45; Michael Rempel et al., Drug Courts an Effective Treatment Alternative, 19 
CRIM. JUST. 34 (Summer 2004). 
41 See, e.g., Bowers, supra note 21, at 788; Hoffman, supra note 2, at 1470–73; Dawn Moore, 
Translating Justice and Therapy:  The Drug Treatment Court Networks, 47 BRIT. J. CRIMINOLOGY 
42, 44 (January 2007). 
42 Bowers, supra note 21, at 788. 
43 Id. 
44 There are other concerns with drug courts addressed in depth in other law review 
articles.  A number of the concerns relate to safeguards for the individual rights of the 
individual participants within the drug court paradigm.  Oram, supra note 6, at 472–73; see 
also, e.g., Bowers, supra note 21, at 803–05.  For example, concerns arise related to equal 
protection and access to drug courts when drug courts are not available uniformly 
throughout the country (this is viewed in the U.S. Constitutional aperture, but may also be 
applied in the international context as no country has developed a thorough and uniform 
system of drug courts throughout the whole of the country).  Oram, supra note 6, at 480–85.  
Cases involving the question of equal protection have generally found that drug courts do 
not violate the offender‘s equal protection rights because treatment is not viewed as a 
fundamental right and drug users do not constitute a suspect class.  Id. at 482–83.  
Additionally, drug courts pass the rational relationship test because they are rationally 
related to a legitimate state objective.  Id.  The next individual right implicated in the drug 
court context has to do with due process rights in the entry process.  It has been argued that 
the complex nature of drug court plea bargains make it difficult for a defendant to enter the 
plea knowingly and intelligently, that a number of due process rights must be understood 
and waived, and that the lack of alternatives to entering a drug court plea result in a 
coercive setting where the defendant sees the drug court plea as the only rational option.  
Id. at 492–518; see also Bowers, supra note 21, at 802–03.  Most of these concerns are or can be 
addressed by the standards put in place to govern plea bargains and ethical conduct by the 
defense attorney and prosecution, as long as each of the actors is aware of the rights 
implicated.  Oram, supra note 6, at 518–19. 
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Despite these concerns, existing statistical and anecdotal evidence 
suggest that drug courts are successful in achieving their stated goals.45  
Fiscal savings, treatment success, and reduced rates of recidivism are all 
used to demonstrate the success of drug courts.46  According to the Drug 
Court Clearinghouse Technical Assistance Program (―DCCTAP‖) in a 
1998 report reviewing the first ten years of drug courts in America, drug 
courts have been extremely successful in reducing recidivism by drug 
users (particularly for drug court graduates), providing increased 
monitoring and treatment supervision and promptly dealing with 
relapse and other issues related to long-term treatment.47  Furthermore, 
drug courts have been able to achieve high numbers of retention, better 
results for families and children of participants, cost-savings, more time 
for courts to deal with violent and other criminal cases, the provision of 
other necessary treatments (such as mental health and physical health), 
and significant growth and organization of programs around the 
country.48  Additionally, stories reflecting the positive benefits of drug 
courts are effectively used to tout the benefits of drug courts in the 
legislature and in the media.49 
                                                 
45 See Hora, Schma & Rosenthal, supra note 1, at 502–08 (―[Drug courts] across the 
country have recorded substantial success in retaining participants in treatment programs, 
reducing recidivism rates, and saving criminal justice system resources.‖). 
46 Id. 
47 Decade of Drug Courts, supra note 28. 
48 Id. 
49 See Kevin Behr, Wabasha County Drug Court is Turning Around People’s Lives, WINONA 
DAILY NEWS, June 22, 2008 (describing the story of a Minnesota drug court participant who 
credits the drug court with changing her life).  The participant had been addicted to alcohol 
and methamphetamines for over twenty years when she was admitted into drug court.  Id.  
She had been in and out of court-ordered treatment several times and had served time in 
jail in the past.  Id.  At the time she entered drug court, she was facing seven years in prison 
and her two children had been placed in foster care.  Id.  As a participant in the drug court 
program, she was able to overcome a life of addiction, keep her children, and stay out of 
prison.  Id.  She has remained clean and sober for over four years.  Id.  She attributes her 
success to the supervision and support she received while in the drug court program.  Id.; 
see also innovation Research & Training, Inc., Durham County Adult Drug Treatment Court 
Process Evaluation Report 93 (2005), available at http://www.nccourts.org/Citizens/ 
CPrograms/DTC/documents/durham_adultdtc_eval_final.pdf [hereinafter Durham 
County Report].  This report was based on a comprehensive study of Durham County Drug 
Court, a court-supervised, post-plea drug treatment court administered by North Carolina 
Administrative Office of the Courts.  Durham County Report, supra, at 92.  ―Both team 
members and participants report that the program has had a significant positive impact on 
the lives of participants, including the reduction or elimination of drug and/or alcohol use, 
improved family relations, and improved financial and employment stability.‖  Id. at 93.  
Arguably, success stories like the ones described above have a more powerful and lasting 
impact on lawmakers and community members than any statistical data that can be 
provided. 
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Despite the arguments in favor of drug courts, these courts will 
continue to face challenges in the future.  Perhaps the most urgent is that 
the current economic situation has put pressure on court systems across 
the country to cut costs, and drug courts could end up on the chopping 
block in a number of jurisdictions.50 
III.  SURVEY OF DRUG COURTS AROUND THE WORLD 
In addition to tremendous growth in the number of drug courts in 
the United States, drug courts have developed at an astonishing rate 
across the globe.  The first drug court outside of the United States 
became operational in Toronto, Canada, on December 1, 1998.51  Courts 
have continued to develop in countries as diverse ―as Australia, Jamaica 
and Ireland.  [Additionally, t]here are currently drug treatment courts 
operating or planned in Brazil, Cayman Islands, Bermuda, Trinidad, 
Barbados, New Zealand, Scotland, Norway, Italy, and Macedonia.‖52 
According to the International Association of Drug Treatment Courts 
(―IADTC‖), there are approximately fifteen countries using or planning 
to use a system of drug courts around the world.53  Additionally, a 
number of other countries are using other systems of diversion to 
address the growing number of drug-related cases that are backing up 
their justice systems.54  And still, the leadership in other countries is 
calling for the formation of specialized drug treatment courts where 
none currently exist.55  While programs in countries other than the U.S. 
are still largely in their formative stages, the majority of the feedback 
from the individual programs is positive.  The countries report various 
                                                 
50 One illustration of this situation can be seen in Minnesota where courts are facing 
several millions of dollars in cuts to their budgets.  See Patrick Thornton, Courts Express 
Concern Over Minnesota Governor’s Proposed Funding Cut, THE MINN. LAW., Feb. 22, 2010 
(stating that staffing and funding for ―programs aimed at reducing recidivism, like drug 
courts, will be discontinued‖). 
51 About the IADTC, INT‘L ASS‘N OF DRUG TREATMENT COURTS, http://www.iadtc.law. 
ecu.edu.au/about/index.html (last visited Sept. 24, 2010). 
52 Id. 
53 Id.  These countries include:  England, Canada, Australia, New Zealand, Jamaica, 
Ireland, Brazil, Cayman Islands, Bermuda, Trinidad, Barbados, Scotland, Norway, Italy, 
and Macedonia.  Id. 
54 See Michael S. King, Magistrate, Perth Drug Court, Challenges Facing Australian 
Court Drug Diversion Initiatives, Keynote Address at the Court Drug Diversion Initiatives 
Conference (May 25–26, 2006) (transcript available at http://www.aic.gov.au/events/ 
aic%20upcoming%20events/2006/drugdiversion.aspx). 
55 See Michael Punongbayan, Dangerous Drugs Board Calls for Creation of Special Drug 
Courts, THE PHIL. STAR, Jan. 18 2010, available at http://www.philstar.com/Article.aspx? 
articleId=541754&publicationSubCategoryId=63 (stating that the board on dangerous 
drugs calls for the formation of drug treatment courts in the Philippines). 
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benefits, such as increased collaboration between agencies providing 
services to participants,56 better support options for participants,57 
reduced rates of recidivism,58 and cost-savings.59  This section gives a 
brief survey of drug courts from different areas of the world. 
A. Canada 
About a decade after drug courts began in the United States, the first 
drug court opened its doors in Canada.60  Toronto‘s drug treatment court 
opened its doors in December 1998.61  Six drug treatment courts are 
currently operating in Canada.62  These courts include:  Edmonton 
(December 2005), Winnipeg (January 2006), Ottawa (March 2006), and 
Regina (October 2006), in addition to the existing drug treatment courts 
that continue to operate in Toronto (December 1998) and Vancouver 
(December 2001).63  ―All of these programs, as a condition of their 
funding, are responsible for developing site-specific results-based 
evaluation/accountability frameworks, as well [as] contributing to the 
national evaluation/accountability framework.‖64 
The drug court pilot program began in Canada in 1998.65  The 
program is based in Toronto and is aimed at prostitutes, youth, and 
identifiable minorities, but does allow for other drug offenders with 
eligible offenses to be a part of the program.66  In contrast to the U.S. 
model, which favors abstinence from all drug use, the Toronto Drug 
Treatment Court uses a harm-reduction model.67  Therefore, use of 
illegal drugs while participating in the program will not result in 
                                                 
56 Drug Court, COURTS ADMIN. AUTH. S. AUSTL. (Aug. 12, 2009) http://www.courts.sa. 
gov.au/courts/drug_court/index.html [hereinafter S. AUSTL.]. 
57 Id. 
58 Facts on Drug Courts, CONSULATE GEN. OF THE U.S. SAO PAOLO BRAZ., 
http://www.embaixada-americana.org.br/index.php?action=saopaulomateria.php&id= 
8455&submenu=14&itemmenu=165 (last visited Sept. 24, 2010) [hereinafter BRAZIL]. 
59 Expanding Drug Treatment Courts in Canada, DEP‘T OF JUSTICE CAN., 
http://www.justice.gc.ca/eng/news-nouv/nr-cp/2005/doc_31552.html (last visited Sept. 
24, 2010); see also BRAZIL, supra note 58. 
60 Expanding Drug Treatment Courts in Canada, supra note 59. 
61 Id. 
62 Drug Treatment Court Funding Program, DEP‘T OF JUSTICE CAN., http://www.justice.gc. 
ca/eng/pi/pb-dgp/prog/dtc-ttt/index.html (last visited Sept. 24, 2010). 
63 Id. 
64 Id. 
65 Walker, supra note 35, at 24. 
66 Id. 
67 Id.; see also Drug Treatment Court Funding Program, supra note 62 (explaining that the 
Canadian model is aimed at reducing the harm people cause to themselves and to others 
through their drug use, as well as reducing the risk that these individuals will continue to 
use drugs and thereby come into conflict with the law). 
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sanctions.68  Instead, the participant is successful when he or she has 
achieved a positive lifestyle change such as stopping cocaine or heroin 
use, but occasionally using marijuana or alcohol.69  When they complete 
the program, these participants may still be on a probationary period 
and will be expected to end all illegal drug use.70 
While the ultimate goal is not necessarily abstinence but rather harm 
reduction, the principles that govern Canadian drug courts are very 
similar to those in the United States.  ―Drug Treatment Courts aim to 
reduce crime committed as a result of drug dependency through court-
monitored treatment and community service support for offenders with 
drug addictions.‖71  The Canadian model draws a great deal from the 
U.S. Drug Court model in other respects.  The Canadian model uses a 
two-track method for entering offenders into the program.  The first 
track allows offenders with little or no criminal record and a charge of 
possession of a controlled substance to enter the program without a plea 
in a deferred sentencing model.  Offenders with a more serious criminal 
record and/or charges of drug trafficking are moved into track two, 
which requires the offender to enter a plea in a post-adjudicative 
model.72 
Additionally, Drug Treatment Courts ―aim to reduce the burden of 
substance abuse on the Canadian economy.‖73  The estimated annual 
impact of substance abuse on the Canadian economy, including costs 
related to law enforcement, prosecution, and incarceration, is estimated 
at $9 billion.74 
The structure of the drug treatment court program is that of an 
outpatient program.75  The participants attend individual and group 
counseling sessions.76  The participants receive appropriate medical 
attention, which may include methadone treatment, and are subject to 
random drug tests.77 
Like in the United States, participants are required to make regular 
court appearances and the court has the ability to impose sanctions for 
failure to comply with the program requirements.78  These sanctions can 
                                                 
68 Walker, supra note 35, at 24. 
69 Id. 
70 Id. 
71 Expanding Drug Treatment Courts in Canada, supra note 59. 
72 Id. 
73 Id. 
74 Id. 
75 Id. 
76 Id. 
77 Id. 
78 Id. 
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range from verbal reprimands to expulsion from the program.79  The 
judge can also provide rewards for compliance such as verbal 
commendations or reducing the number of required court appearances.80 
Community partners also address the participant‘s other basic needs 
―such as safe housing, stable employment and job training.‖81  Success in 
the program is achieved when the participant attains a level of social 
stability and can demonstrate a level of control over his or her 
addiction.82  At that time, the criminal charges may be stayed or the 
participant may receive a non-custodial sentence.83 
B. Australia 
Australia implements two main alternatives to conventional 
sentencing when addressing drug-related offenses:  drug courts and 
court diversion programs.84  Drug courts typically address more serious 
offenders and require a more intense program with longer time frames 
and follow similar frameworks to U.S. drug courts.85  Court diversion 
programs tend to deal with less serious offenses, and there is often less 
or no involvement by the court in the management of the offender‘s 
treatment.86 
Australia‘s drug diversion programs have been a part of its judicial 
system for over thirty years, while drug courts are a relatively new 
development with the first such court established in 1999.87  Australian 
drug courts use a harm-reduction model for its participants.88  In 
Australia, as in the United States, drug courts developed out of a need to 
                                                 
79 Id. 
80 Id. 
81 Id. 
82 Id. 
83 Id.  ―[S]tayed (meaning a judgement [sic] is suspended or postponed) or the offender 
receives a non-custodial sentence (meaning restrictions other than jail, including house 
arrest).‖  Id. 
84 King, supra note 54, at 1.  Courts in the United States have also used diversionary 
sentencing as a means of addressing drug offenders, but this is done at the discretion of the 
court and not within a structured program. 
85 Id. 
86 Id.; see also TIM MCSWEENEY, ET AL., CRIMINAL POLICY RESEARCH UNIT, REVIEW OF 
CRIMINAL JUSTICE INTERVENTIONS FOR DRUG USERS IN OTHER COUNTRIES 2 (2002) (stating 
that diversion at the point of arrest is commonly used throughout Australia but that little 
research has been collected on the effectiveness of these schemes).  The diversion program 
in Australia is somewhat more akin to the expedited drug case management courts that 
exist in the United States. 
87 King, supra note 54, at 2. 
88 Drug Court, DEP‘T OF JUSTICE VICT., AUSTL., http://www.justice.vic.gov.au/wps/ 
wcm/connect/DOJ+Internet/Home/Courts/Victorian+Courts/JUSTICE+-+Drug+Court 
(last visited Sept. 24, 2010) [hereinafter DEP‘T OF JUSTICE VICT.]. 
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address the unique nature of drug addiction and the vast number of 
related cases entering the courts.89  Similar to the United States, 
Australian drug courts are state initiatives and vary from state to state 
but are dependent on federal funding.90  This has resulted in an 
increased need for better planning, better communication, and better 
integration of existing programs as drug courts continue to grow and 
develop throughout the country.91 
The drug court program that the participant undergoes in Australia 
may consist of a number of different stages.92  The participant is taken 
through a withdrawal management program, which may include in-
patient detoxification if necessary and pharmacological treatment, such 
as methadone, as needed.93  Relapse prevention is provided in the form 
of individual counseling or group therapy.94  Group therapy and 
individual counseling may also be employed to assist with developing 
―pro-social thoughts and behaviours.‖95  Other measures may include 
prevention of additional offenses through restricted bail, referral to other 
agencies to assist with the management of physical and mental health 
issues, education and vocational training, temporary housing for up to 
fifteen months and referral to access long-term housing, assistance to 
restore familial relationships, referrals to other agencies to obtain income 
support and to manage financial issues, support to find or maintain 
employment, and practical assistance for those leaving detention in the 
form of basic personal and food items until other support can be 
arranged.96  The Australian drug courts even set aside funding to 
purchase services where none may exist.97 
This holistic view of treatment exemplifies a model of harm 
reduction.  By focusing on rehabilitation, the Drug Courts‘ treatment 
program represents a fundamental shift in the way courts deal with drug 
offenders.  ―The ultimate goal of the program is to address drug 
dependency, bring stability to offenders‘ chaotic lifestyles and break the 
cycle of offending.‖98 
In Australia, ―[one] report emphasizes [sic] the positive benefits 
experienced by drug court participants who embrace the opportunity for 
                                                 
89 King, supra note 54, at 2. 
90 Id. at 3. 
91 Id. 
92 S. AUSTL., supra note 56. 
93 Id. 
94 Id. 
95 Id. 
96 Id. 
97 Id. 
98 DEP‘T OF JUSTICE VICT., supra note 88. 
Valparaiso University Law Review, Vol. 45, No. 1 [2010], Art. 4
https://scholar.valpo.edu/vulr/vol45/iss1/4
2010] Twenty Years of Drug Courts 87 
rehabilitation.  Successful offenders consistently report a large decline in 
their criminal activity and lower rates of recidivism than those who were 
unsuccessful or those who were sent to prison.‖99 
C. England/Wales 
Drug courts in England and Wales first began to appear in 1997.100  
There were a number of different models established, including some 
referral or diversion schemes provided at arrest that allow for drug 
offenders to enter treatment voluntarily.101  On the basis of the success of 
the early drug courts in England and in other countries such as the 
United States and Scotland as well as the growing costs of drug abuse 
and acquisitive crime, England started a Dedicated Drug Court pilot 
model in February 2005 to evaluate the benefits and costs of the system 
before wider implementation of the model.102  English research based on 
programs from other countries found that a holistic approach toward 
drug treatment can offer benefits, such as increased engagement and 
improved chances for completion of treatment resulting in a reduction of 
drug usage and related offenses.103 
The Dedicated Drug Courts operated with five distinguishing core 
characteristics as follows: 
 Specialism:  the DDC exclusively handles cases 
relating to drug-misusing offenders from conviction 
through sentence, to completion or breach of their 
orders. 
 
 Continuity:  the DDC will try to ensure sustained 
continuity of magistrates‘ bench or district judge 
throughout the period an offender comes before the 
DDC. 
 
                                                 
99 JASON PAYNE, AUSTRALIAN INSTITUTE OF CRIMINOLOGY, THE QUEENSLAND DRUG 
COURT:  A RECIDIVISM STUDY OF THE FIRST 100 GRADUATES, 2008 RES. & PUB. POLICY SERIES 
83, at iii, available at http://www.aic.gov.au/documents/7/C/C/%7B7CCCCFD2-FFF6-
4DAB-B17F-49700902BC1D%7Drpp83.pdf. 
100 MINISTRY OF JUSTICE, RESEARCH SERIES 7/08, DEDICATED DRUG COURT PILOTS:  A 
PROCESS REPORT 2 (2008), available at http://www.justice.gov.uk/docs/dedicated-drug-
courts.pdf. 
101 MCSWEENEY, supra note 86, at 2. 
102 MINISTRY OF JUSTICE, supra note 100, at iii.  ―Drug misuse is estimated to give rise to 
social and economic costs of between £10 and £18 billion per year.‖  Id. at 1. 
103 Id. at 9. 
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 Training:  sentencers and other court staff receive 
additional training on working with drug-misusing 
offenders and the DDC model. 
 
 Processes:  processes are designed to ensure all 
necessary information is before the court when 
required. 
 
 Partnership:  the DDCs are designed to ensure 
effective multidisciplinary working with other 
criminal justice system agencies and professionals.104 
The goal is that through the Dedicated Drug Court pilots, the court 
would better understand the needs and motivations of the offenders, 
which will result in more effective sentencing, greater participation in 
treatment, and higher levels of sentence completion.105 
On the basis of the information gathered from this pilot program, 
England and Wales have established a clear plan for implementing 
Dedicated Drug Courts in a greater number of locations.106  Among the 
chief concerns are establishing a proper location for the courts, 
determining likely number of participants for the area, adequate and 
specialized training, and making sure the court is properly staffed and 
that there are adequate physical accommodations and resources to 
successfully implement the court.107  While the Dedicated Drug Courts 
are relatively new, the early studies of these courts have indicated 
success in the development of the courts and in the results for 
participants in the courts.108 
D. Scotland 
The first drug court in Scotland was established in October 2001 in 
the Glasgow Sheriff‘s Summary Court.109  The Glasgow Drug Court is 
                                                 
104 Id. at iv. 
105 Id. 
106 Id. at 43. 
107 Id. at 43–46. 
108 See Review of the Effectiveness of Specialist Courts in Other Jurisdictions, HOME OFFICE 
CRIME REDUCTION, http://webarchive.nationalarchives.gov.uk/20100413151441/http:/ 
www.crimereduction.homeoffice.gov.uk/criminaljusticesystem15.htm (last visited Sept. 
24, 2010) (listing the findings and conclusions of a study on the effectiveness of specialist 
courts). 
109 The Glasgow Drug Court in Action:  The First Six Months, THE SCOTTISH GOV‘T, 
http://www.scotland.gov.uk/publications/2002/11/15741/12688 (last visited Sept. 24, 
2010). 
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focused on adult offenders who are age twenty-one or older, and who 
have ―an established relationship between a pattern of serious drug 
misuse and offending and whose drug misuse is susceptible to 
treatment.‖110  The offenders must be facing prosecution in court and 
normally first appear in the summary court from custody.111 
The drug court staff consists of the Drug Court Sheriffs, the Sheriff 
Clerk, the Drug Court Procurator Fiscal (identifies potential referrals and 
deals with new charges and breaches of drug court orders), and the 
Project Leader of the Drug Court Supervision and Treatment Team.112  
―A Drug Court Co-ordinator facilitates the work of the Drug Court 
Team.‖113 
Initial referrals to the Drug Court were dependent on the arresting 
officers‘ knowledge of and enthusiasm for the program.114  Despite this, 
the program appeared to be identifying appropriate candidates for the 
program.115  Sentencing options within the Drug Court were similar to 
those available in summary court; however, there appeared to be greater 
flexibility and dialogue during the sentencing in the Drug Courts.116  
Scotland also employs a harm-reduction model, which includes the use 
of methadone treatment to help participants wean off of drug use.117  The 
initial findings have been positive in regard to the success of the first 
drug court pilot; the following areas have been identified as potential 
problems:  police contribution in the referral process, need for a broader 
range of rewards and sanctions, workload of treatment team members, 
and team work among the multi-disciplinary professionals.118  The 
Scotland drug courts also find support in the fact that other problems 
facing drug court participants, such as housing, benefits, and child care, 
are funded by other agencies within the country, while drug courts in 
the United States tend to provide the funding for these support 
services.119 
                                                 
110 Id. 
111 Id. 
112 Id.  The Drug Court Supervision and Treatment Team consists of a Drug Court 
Medical Officer, a senior social worker, a senior dedicated worker from Phoenix House, the 
voluntary organization contracted to provide treatment services, a representative of the 
police, and a representative of the Glasgow Bar Association.  Id. 
113 Id. 
114 Id. 
115 Id. 
116 Id. 
117 MINISTRY OF JUSTICE, supra note 100, at 16. 
118 See Glasgow Drug Court in Action, supra note 109. 
119 Walker, supra note 35, at 30. 
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The success of the program has encouraged the Scottish government 
to continue funding drug courts after the initial pilot.120  While there has 
been some concern that high numbers of participants are reconvicted 
after participation in the program, evidence suggests that participants 
who complete the full treatment prescribed in the drug court sentencing 
are reconvicted at a much lower rate than those who breached their 
order or had their orders revoked.121 
E. Ireland 
In Ireland, the Drug Treatment Court was established in Dublin in 
2001.122  Like England, the Irish courts began with a pilot program.  This 
pilot court started in Dublin North Inner City.123  The focus of the court 
was to treat rather than imprison drug users.124  Only non-violent 
offenders motivated by addiction (as opposed to financial gain) are 
admitted to the program.125  The program aims to provide long-term 
supervised treatment with the central principle of the program to deal 
with or eliminate the addiction thereby eliminating the need to offend.126  
The pilot program was extended in 2003 for a longer period of time and 
to an expanded target area.127  In 2006, the program was expanded to 
include the city of Dublin.128 
                                                 
120 See Drug Courts’ Three-Year Extension, BBC NEWS (Mar. 30, 2006, 13:46 GMT), 
http://news.bbc.co.uk/2/hi/uk_news/scotland/4860874.stm (reporting that drug courts 
were granted a three year extension in 2006).  ―Drug courts allow us to continue to develop 
intensive interventions to help people with complex and deeply entrenched drug problems 
to turn their lives around and turn their backs on crime.‖  Id. 
121 Review of Glasgow and Fife Drug Courts:  Report, CMTY. JUSTICE SERVS. SCOTTISH GOV‘T 
1317, http://www.scotland.gov.uk/Resource/Doc/299438/0093354.pdf (last visited Sept. 
24, 2010).  ―It is encouraging that those who had an early discharge, or who had completed 
their Order, had a lower reconviction rate compared to those who had breached or been 
revoked.  This appears to suggest that those with the resolve to complete their Order, also 
committed less subsequent crimes.‖  Id. at 14. 
122 INFO. OFFICE, COURTS SERV., PUB. INFO. LEAFLET, THE DRUG TREATMENT COURT 2 (Feb. 
2005), available at http://www.courts.ie/Courts.ie/library3.nsf/(WebFiles)/DA10E72CEB 
411A0E80257297005BD8C9/$FILE/Drug%20Treatment%20Court%20-%20public%20info. 
pdf [hereinafter PUBLIC INFORMATION LEAFLET]. 
123 About the Courts, COURTS SERV. OF IR., http://www.courts.ie/courts.ie/Library3.nsf/ 
pagecurrent/10646F81427562D480256DA9004139B7 (last visited Sept. 25, 2010).  Dublin 
North Inner City was chosen as the target area for the pilot stage of the project.  Id.  ―This 
decision was influenced by the greater availability of treatment programmes in that area 
than in the rest of the Eastern Health Board region.‖  Id. 
124 Id. 
125 Id. 
126 Id. 
127 Id. 
128 Id. 
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The Irish also use a harm-reduction model and the program operates 
in three phases.129  The first phase is called Stabilization and Orientation 
and is aimed at reducing the participant‘s use of drugs and becoming 
involved in a treatment and education program.130  Phase two is called 
Consolidation and Progression, and the goal of this phase is to have 
participants tackle specific areas of their lives that need improvement, 
such as having a plan for future employment, and to continue education 
and treatment from the first phase.131  Finally, phase three is called Re-
Integration and Self-Management, wherein the participant is responsible 
for taking full control of the positive changes in his or her life and for 
maintaining a reduction in drug use.132  The participant should also have 
developed strategies for stress management and self-control.133  Upon 
successfully completing all phases of the program, the participant 
graduates from the Drug Treatment Court program.134 
F. Jamaica 
Drug courts have been established in Kingston and Montego Bay 
over the last couple years.135  Jamaica is the first Caribbean country to 
develop a drug court program.136  The participants in the Jamaican drug 
courts are admitted based on offense (drug-related) and level of 
motivation.137  On the basis of the level of motivation and assessment of 
the individual‘s likelihood of success, the participant may be placed in 
an inpatient (residential) treatment program or an outpatient program.138  
The program teaches the participants about the psychology and 
physiology of addiction, as well as enforces social skills of punctuality 
and a groomed appearance.139  An early study of the Jamaican drug 
courts have reported that drug courts have helped to address social ills 
                                                 
129 Drug Court Treatment Programme, COURTS SERV. OF IR., http://www.courts.ie/offices. 
nsf/lookuppagelink/5C3FCB8E070ADAA280256E7B003B1D9F (last visited Sept. 25, 2010). 
130 PUB. INFO. LEAFLET, supra note 122, at 3. 
131 Id. 
132 Id. at 4. 
133 Id. 
134 Id. 
135 L. Linton & L. Mendez, Drug Abuse Offenders Get Second Chance, JAM. INFO. SERV., Dec. 
25, 2007, http://www.jis.gov.jm/justice/html/20071225t190000-0500_13871_jis_drug_ 
abuse_offenders_get_second_chance.asp. 
136 Id. 
137 Id. 
138 Id. 
139 Id. 
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related to drug abuse and crime.140  There is additional anecdotal 
evidence to support the success of drug courts in Jamaica.141 
G. Brazil 
Brazil has adopted a system referred to as therapeutic jurisprudence 
to implement its drug courts.142  The drug court program in Brazil 
―supports any program that intends to reduce harm to the drug 
user/dependent‘s health, in as much as he does not contemplate the 
replacement of one illicit drug with another, due to the simple fact that 
involvement with illicit drugs is illegal.‖143  This concept of therapeutic 
jurisprudence is a new paradigm that focuses on eliminating the drug 
problem in Brazil and has been widely supported by various 
governmental departments and other organizations.144  Studies in Brazil 
have found that drug courts not only lower crime rates, but they also 
provide a cost-savings to the public.145 
                                                 
140 Regional Drug Treatment Courts Yielding Positive Results, Says OAS Study, JAM. 
OBSERVER, Apr. 30, 2010, http://www.jamaicaobserver.com/news/-p-Regional-drug-
treatment-courts-yielding-positive-results--says-OAS-study--p-- (―[T]he study presents a 
positive picture of what drug treatment courts in the countries involved have accomplished 
in providing treatment to local populations and in addressing the social ills and costs of 
drug abuse and crime.‖); see also CARIBBEAN DRUGS:  FROM CRIMINALIZATION TO HARM 
REDUCTION 83 (Axel Klein, Marcus Day & Anthony Harriot eds., 2004). 
141 Linton & Mendez, supra note 135.  One story from a drug court in Jamaica refers to the 
program as a life changing experience.  Id.  The participant states, ―It help mi fi stop drink 
and stop smoke, so I find my life better off and everything change, so I‘m a new person 
now. I think it help me a lot, because I‘m 40 now and I‘ve been smoking since I‘m 14 years 
old.‖  Id.  This participant wanted to see the program to its completion so that he could be 
rehabilitated.  Id.  He advises, ―I can tell all the youth dem out there wha smoking the weed 
and making trouble, if they could find somebody to introduce them to [drug court] to help 
them, it would be better off for them to stop smoking, we would be a better country, less 
violence and everything.‖  Id. 
142 Carmen Silvia Có Freitas & Ricardo de Oliveira Silva, Therapeutic Jurisprudence Applied 
in Brazil:  “Therapeutic Justice” (DTC) The Brazilian Program for Drug Users Offenders, 
ASSOCIAÇÃO BRASILEIRA DE JUSTIÇA TERAPÊUTICA, http://www.abjt.org.br/index.php? 
id=59 (follow ―ARTICLES‖ hyperlink) [hereinafter ASSOCIAÇÃO]. 
143 Id. 
144 Id.  ―[I]t has received unconditional support from the National Penitentiary and 
Criminal Politics Council, Brazilian Association of Alcohol and Other Drug Studies, 
Department of Legal Psychiatry of the Federal Medicine School Foundation, as well as 
from other mental health professionals in the country.‖  Id. 
145 BRAZIL, supra note 58.  Seventy-five percent of drug court graduates remain arrest-free 
two years after leaving the program.  Id.  Drug courts reduce crime rates more than thirty-
five percent over other sentencing options.  Id.  Additionally, for every dollar spent on drug 
courts, the taxpayer saves $3.36.  Id.  Overall, $4,000 to $12,000 is saved on drug court 
clients.  Id. 
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The program has been applied to both juveniles and adults and can 
begin at any stage of the criminal prosecution process.146  The program 
may include treatment through public or private services.  Again, the 
program casts a wider net than simply examining the participant‘s drug 
addiction.  The program looks at the socioeconomic conditions and 
support networks when designing treatment options.147 
IV.  DRUG TREATMENT MODELS 
A. Background Information About Drug Treatment 
There is no consensus regarding the best course of treatment for 
drug addiction.  Theorists have come up with some basic precepts about 
addiction that form the basis for how drug treatment is approached in 
the United States and around the world.148 
It is important to understand that the degree of severity of substance 
abuse ranges on a continuum and is different for each abuser.149  The 
                                                 
146 ASSOCIAÇÃO, supra note 142. 
147 Id. 
148 See William R. Miller & Kathleen M. Carroll, Drawing the Science Together:  Ten 
Principles, Ten Recommendations, in RETHINKING SUBSTANCE ABUSE:  WHAT THE SCIENCE 
SHOWS, AND WHAT WE SHOULD DO ABOUT IT 294–301 (William R. Miller & Kathleen M. 
Carroll eds., 2006) (discussing ten principles of drug use addiction).  Miller and Carroll list 
ten principles derived from scientific study.  Id. at 294.  1.  ―Drug Use Is Chosen 
Behavior‖—intentional change plays a prominent role in drug treatment.  Id. at 294–95.  2.  
―Drug Problems Emerge Gradually and Occur along a Continuum of Severity‖—drawing 
lines at different stages of addiction such as abuse and dependence may lead to arbitrary 
cut points.  Id. at 296.  3.  ―Once Well Established, Drug Problems Tend to Become Self-
Perpetuating.‖  Id. at 296.  4.  ―Motivation is Central to Prevention and Intervention‖—
choice/decision point.  Id. at 297.  Personal commitment is a component of this principle.  
Id.  5.  ―Drug Use Responds to Reinforcement‖—using drugs is a form of providing the 
user with positive reinforcement so the elimination of use eliminates one way the user has 
to give reinforcement.  Id. at 298. 
Some effective medications reduce the reward value of drug use, 
which can enhance the appeal of alternative reinforcers.  Maintenance 
medications that successfully compete with preferred drug use offer 
reinforcement that is longer lasting but less intense than that obtained 
from drugs of abuse.  Providing clear incentives for abstinence often 
yields rapid reductions in drug uses. 
Id.  6.  ―Drug Problems Do Not Occur in Isolation, but as Part of Behavior Clusters.‖  Id. at 
298–99.  7.  ―There Are Identifiable and Modifiable Risk and Protective Factors for Problem 
Drug Use.‖  Id. at 299.  8.  ―Drug Problems Occur within a Family Context.‖  Id. at 300.  9.  
―Drug Problems Are Affected by a Larger Social Context.‖  Id. at 30001.  10.  ―Relationship 
Matters.‖  Id. at 301. 
149 ARNOLD M. WASHTON & JOAN E. ZWEBEN, TREATING ALCOHOL AND DRUG PROBLEMS 
IN PSYCHOTHERAPY PRACTICE:  DOING WHAT WORKS 24 (2006). 
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continuum is as follows:  experimental use occasional use regular use 
circumstantial or situational use binge use abuse dependence.150 
There are a number of factors that complicate the treatment of drug 
abuse.  One complication is the concurrent existence of other mental 
disorders.151  Additionally, addiction to multiple drugs is becoming more 
prevalent and presents an additional problem in successful treatment of 
―polydrug addiction‖ and ―polypharmacy in treatment.‖152  Other 
factors also alter the nature of a user‘s substance abuse problem.  These 
include family substance abuse, generational differences, child abuse, 
emotional disorders, peer pressure, and media influences.153  Specialized 
services are often necessary to address the significant problems in other 
areas of the participants‘ lives like health issues, family issues, 
employment, and related issues.154 
The assessment of a user‘s substance abuse problems is complex and 
should consist of a variety of measures.155  After the issues facing a drug 
user have been identified, the treatment may proceed with any range of 
therapies.  These therapies may include:  brief and early intervention, 
teaching problem-solving skills, drink and drug refusal skills, 
assertiveness skills, communication skills, cognitive therapy, relaxation 
training, behavioral self-management, involving concerned others, 
pharmacotherapies, self-help groups, and continuing care.156 
Success of treatment is also dependent upon a number of outside 
factors.  Two of the variables in success after treatment are a continued 
exercise program and satisfactory living arrangements after treatment 
                                                 
150 Id. at 24–26. 
151 CARLTON K. ERICKSON, THE SCIENCE OF ADDICTION:  FROM NEUROBIOLOGY TO 
TREATMENT 177 (2007).  Examples of conditions that are frequently associated with drug 
abuse include chronic pain, Parkinsonism, schizophrenia, clinical depression, anxiety and 
panic disorders, ADHD, OCD, and PTSD.  Id.; see also Durham County Report, supra note 49, 
at 93 (finding that in the Durham County drug courts challenges existed in finding the 
right treatment and eligibility for participants when other mental health concerns were 
present in participants). 
152 GENNARO OTTOMANELLI, ASSESSMENT AND TREATMENT OF CHEMICAL DEPENDENCY 
152 (2001). 
153 Id. at 158–63. 
154 A. Thomas McLellan, What We Need Is a System:  Creating a Responsive and Effective 
Substance Abuse Treatment System, in RETHINKING SUBSTANCE ABUSE:  WHAT THE SCIENCE 
SHOWS, AND WHAT WE SHOULD DO ABOUT IT 284–85 (William R. Miller & Kathleen M. 
Carroll eds., 2006). 
155 ROBERT D. MARGOLIS & JOAN E. ZWEBEN, TREATING PATIENTS WITH ALCOHOL AND 
OTHER DRUG PROBLEMS:  AN INTEGRATED APPROACH 91 (1998). 
156 TRACEY J. JARVIS, JENNY TEBBUTT, RICHARD P. MATTICK & FIONA SHAND, TREATMENT 
APPROACHES FOR ALCOHOL AND DRUG DEPENDENCE:  AN INTRODUCTORY GUIDE vii–viii (2d 
ed. 2005). 
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and living with family and continuing with an after-care plan.157  There 
are also negative predictors which indicate that treatment is not likely to 
be successful such as socioeconomic status, financial problems related to 
alcohol, and ongoing emotional distress.158 
Challenges also exist when participants are subjected to treatment 
when there is no personal desire on the part of the participant to be in 
treatment.159  Data suggests that ―the great majority of those who do go 
to treatment have been pressured or forced into that treatment by their 
spouse, employer, the legal system, or the welfare system.‖160  Couple 
that with the fact that ―[e]ven with the threat of punishment hanging 
over their heads, the great majority of those who enter substance abuse 
treatments leave prematurely.‖161  This is particularly problematic in the 
context of drug courts where, arguably, all of the participants are there 
based on external pressures.  The unfortunate reality ends up being that 
―more than half of those who complete the recommended duration of 
addiction treatment relapse to alcohol and drug use within 6 months 
following their discharge.‖162 
Generally, drug treatment can be looked at in three different phases:  
detoxification or stabilization, rehabilitation, and continuing care.163  In 
the first phase, the treatment team prepares an unstable patient to do 
well in the subsequent rehabilitation phase.164  Detoxification alone is 
unlikely to be sufficient to set a participant on a lasting course of 
recovery.165  The second phase begins when patients are not suffering 
from the effects, acute physiological or emotional, of the recent substance 
abuse.166  In this phase, the goals are to prevent the patient from 
relapsing, to assist the patient in developing tools to overcome or control 
urges, and to help the patient regain personal health or to regain social 
functioning.167  The final phase encompasses the continuing care after 
treatment.168 
                                                 
157 OTTAMANELLI, supra note 152, at 158 (using data from the Minnesota Multiphasic 
Personality Inventory from 1989). 
158 Id. 
159 McLellan, supra note 154, at 275.  ―[T]here is substantial evidence that many of those 
for whom the treatment system was supposedly designed do not want to participate in it.‖  
Id. 
160 Id. 
161 Id. at 275–76. 
162 Id. at 276. 
163 Id. 
164 Id. at 277. 
165 Id. 
166 Id. 
167 Id. 
168 Id. at 278. 
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Studies have shown that there is a reduction in the rate of relapse 
when addiction treatment works concurrently with other counseling to 
address other participant issues and if ―(1) the additional service 
components [are] both needed and desired by the target group; and (2) 
the additional services [are] delivered at an intensity and for a duration 
that is likely to be effective at reducing target problem symptoms.‖169  
Given the varying complexities of each individual case, it is easy to 
understand why a variety of approaches have been taken to match 
patients with treatment plans.170  A final complicating factor that needs 
to be considered in the context of drug courts is the significant rising 
costs related to finding and providing the treatment that is necessary and 
appropriate.171 
B. Treatment Methods 
In order to better understand substance abuse treatment, there needs 
to be some knowledge of the different types of treatment options.  First, 
there are a number of developing and increasingly effective treatment 
programs that use controlled substances to replace illicit drug use and 
assist the patient in stepping down her drug use.172 
The most well-known and widely used method of pharmacological 
treatment is methadone maintenance, which is largely considered 
effective.173  The purpose of using methadone maintenance to treat drug 
                                                 
169 Id. at 285. 
170 Id. 
171 Id. at 286–87. 
172 See id. at 282 (―Great progress has been made in the development of new medications 
and in the application of existing medications for the treatment of particular conditions 
associated with substance dependence and for particular types of substance-dependent 
patients.‖).  To further define what constitutes a ―drug,‖ it is generally considered as ―any 
chemical that changes normal physiology and function in the body and in high doses 
produces a toxicological or harmful effect.‖  ERICKSON, supra note 151, at 113.  Additionally, 
different drugs create differing levels of strength with regard to addiction.  For example, 
Marijuana ―has no known lethal dose in humans, making it one of the safest drugs from a 
pharmacological standpoint.‖  Id. at 136. 
173 Jody L. Sindelar & David E. Fiellin, Innovations in Treatment for Drug Abuse:  Solutions 
to a Public Health Problem, 22 ANN. REV. PUB. HEALTH 249, 252 (2001).  ―Evaluations 
repeatedly demonstrate that despite difficulties with retention and relapse, methadone 
maintenance results in reduction in crime and drug use for those in treatment.‖  Id.  See also 
ERICKSON, supra note 151, at 158–59 (explaining that despite enormous agreement that it is 
useful, methadone is still controversial:  it is not usually an abstinence-based program of 
treatment, there is a misunderstanding that methadone replaces one drug for another, and 
some clinics fail to be run with strict guidelines or control); McLellan, supra note 154, at 283 
(―Twenty years of studies on the effectiveness of methadone were validated by a panel of 
impartial physicians and scientists in a National Institutes of Health consensus conference 
that confirmed major reductions in opiate use, crime, and the spread of infectious diseases 
associated with methadone maintenance.‖). 
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addiction is ―to reduce drug craving, maximize the patient‘s tolerance, 
and eliminate the effects of the lower potency ‗street‘ opiates.  
Methadone has been used effectively as a maintenance medication 
because of its slow onset of action and long half-life.‖174 
There are several considerations for running a successful treatment 
program that utilizes methadone maintenance.  Best practices are 
recommended to make sure that the patient‘s methadone use does not 
become a mere replacement for the patient‘s previous substance 
addiction.  These practices include requiring patients to take oral 
methadone tablets under observation to prevent the concealment and 
reselling of the tablets on the street, regular urine testing, requiring 
patients to have a job and to pay for methadone tablets, and requiring 
counseling in addition to methadone maintenance.175 
Additionally, there are several other medications that are currently 
being used or tested in the arena of drug treatment addiction.  These 
include Buprenorphine and Naltrexone for opiate addictions,176 
Disulfiram for stimulant dependence,177 and additional anticraving 
drugs and abstinence-enhancing drugs that are being developed.178  
However, ―[w]hile the use of opiate and alcohol antagonists or blocking 
agents is increasing as addiction medicine physicians become more 
comfortable in prescribing adjunctive medications and as more 
substance dependence is treated by physicians in office settings, there 
are still relatively few patients who receive or physicians who prescribe 
medication.‖179 
                                                 
174 McLellan, supra note 154, at 283 (parenthesis omitted). 
175 ERICKSON, supra note 151, at 159. 
176 See McLellan, supra note 154, at 283 (explaining the different applications of 
Buprenorphine and Naltrexone for opiate addictions).  Buprenorphine was approved in 
2002 by the FDA and has few or no withdrawal symptoms, unlike methadone, and a lower 
risk of overdose even if combined with other opiates.  Id.  Naltrexone, a drug that has been 
on the market since 1984, is similar to methadone and does not produce euphoria or 
disphoria but has a generally poor compliance rate.  Id.  Naltrexone ―may be most 
useful . . . in selected populations, when combined with social, employment, or criminal 
justice sanctions to increase compliance.‖  Id. 
177 See id. at 284 (explaining that although most medications for stimulant dependence 
―have not shown benefit compared with placebo,‖ Disulfiram is somewhat of an exception 
and has been found to have an effect on cocaine abuse and, therefore, research in this area 
continues). 
178 See ERICKSON, supra note 151, at 174, 235 app. B (listing other drugs to treat cocaine 
dependence:  Disulfiram (antabuse), Gabapentin (neurontin), Modafinal (Provigil), and 
Topiramate (Topamax)).  Vaccines for the treatment of nicotine, cocaine, 
methamphetamine, phencyclidine, and other chemical dependencies are also being 
developed.  Id. at 175. 
179 McLellan, supra note 154, at 284. 
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Other types of treatment outside of pharmacological methods may 
include different types of treatments such as placebo effects, twelve-step 
programs, counseling, moderation management, faith-based treatment, 
and vouchers.180  Office-based therapy is another common treatment 
option.  Patients who can most benefit from office-based treatment with 
a psychotherapist are those individuals who are not serious abusers or 
dependent, individuals seeking a harm-reduction approach, or 
individuals who have had previous treatment experiences that were 
unhelpful or unpleasant.181  Also, individuals who cannot work within 
traditional models, individuals who have other mental health issues in 
addition to substance abuse issues, individuals concerned with privacy, 
individuals who want to be able to select their therapist, individuals in 
early stages of addiction, individuals who have had a sustained period of 
abstinence in the past, individuals who want to supplement group 
therapy, individuals who want to continue therapy after completing 
another program, and individuals who want to supplement a self-help 
program can similarly benefit from office-based treatment.182 
Another approach is the therapeutic community which consists of 
―an intensive, highly structured residential, communal treatment that 
operates according to a somewhat distinct, but not codified, 
philosophy.‖183  The aim of the therapeutic community is to get abusers 
to develop a sense of self-help via a structured reward system and a 
reality-based approach.184 
Some drug addictions cause such massive damage to the drug 
abuser that drug addiction treatment alone will not be sufficient.  For 
example, in the case of methamphetamine addictions, treatment may 
also require addressing a host of other medical conditions including:  
neurological damage, cardiovascular damage, respiratory damage, 
infectious diseases (HIV/AIDS, STDs, Hepatitis C), dental damage, 
dermatological damage, methamphetamine psychosis, and cognitive 
impairment.185  As illustrated, the full scope of treatment for some users 
will go far beyond the treatment of the addiction alone.  Because of this, 
in part, ―[t]here is no uniformly held standard, or even clear consensus, 
                                                 
180 ERICKSON, supra note 151, at 152–56, 162–64.  In a voucher program, patients receive a 
voucher for each week they are drug free—obsession for reward replaces obsession for 
drug.  Id. at 164. 
181 WASHTON & ZWEBEN, supra note 149, at 15–16. 
182 Id. 
183 Sindelar & Fiellin, supra note 173, at 254. 
184 Id. 
185 Kathleen M. Carroll & Samuel A. Ball, Assessment of Cocaine Abuse and Dependence, in 
ASSESSMENT OF ADDICTIVE BEHAVIORS 199–205 (Dennis M. Donovan & G. Alan Marlatt eds., 
2d ed. 2005). 
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regarding an ideal treatment outcome indicator or definition of 
treatment success in [drug] abuse treatment.  Although definitions of 
success are broadening beyond requiring complete abstinence from 
[drug use], meaningful reductions in [drug] use remain a central 
indicator of improvement.‖186 
C. The Abstinence Model 
As mentioned in Section II, drug courts in the United States largely 
follow an abstinence model of drug treatment.  This is a blunt approach.  
In essence, the drug courts take an all or nothing attitude towards 
treatment.  When following an abstinence model, ―[a]bstinence . . . is 
both a key element of treatment and an ultimate goal of most treatment 
programs.‖187  To meet this end, urine testing is a common practice in 
drug treatment court.188  The goal of the treatment program is clear and 
measurable:  when the user is no longer using, the program is complete.  
The abstinence model is not without its difficulties.  As outlined above, 
drug treatment often entails navigating a complicated maze of issues 
that fall both inside and outside the realm of addiction. 
When abstinence from drug use during and after treatment is the 
main goal of the treatment program, there is more room for failure to 
address the underlying problems at the root of the drug addiction.  
Additionally, because addiction is a disease, a complete abstinence 
approach may not be the long-term goal for every drug addict.189 
Additionally, some scientists have observed a mental obstacle to 
successful completion of treatment in abstinence-based therapies.  This is 
called the Abstinence Violation Effect, which is a ―cognitive-affective 
reaction to an initial slip that increases the probability that the lapse will 
be followed by an increased use of the substance or activity.‖190  In other 
words, once the user falls off the wagon once, he is more inclined to have 
an increase in use or have additional uses of the drug in the future. 
D. The Harm-Reduction Model 
―Harm reduction is a public health approach intended to reduce the 
harm done to alcohol and drug users, their loved ones, and 
                                                 
186 Id. at 167 (citation omitted). 
187 Hora & Stalcup, supra note 1, at 761. 
188 Id. at 755–56. 
189 Elizabeth Zelvin & Diane Rae Davis, Harm Reduction and Abstinence Based Recovery:  A 
Dialogue, 1 J. SOC. WORK PRAC. ADDICTIONS 121, 122 (2001). 
190 MARGOLIS & ZWEBEN, supra note 155, at 272 (quoting RELAPSE PREVENTION:  
MAINTENANCE STRATEGIES IN THE TREATMENT OF ADDICTIVE BEHAVIORS 179 (G. Alan 
Marlatt & Judith R. Gordon eds., 1985)). 
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communities.‖191  On the whole, the harm-reduction model looks to 
make the user ―whole‖ in terms of the quality of life that he may achieve 
without the interference of drug addiction.  ―Harm reduction has often 
been described as being technically the antithesis of abstinence-based 
substance abuse treatment despite the fact that there is a great deal 
technically in common within these theoretical contexts.‖192  Although 
both methods aim to achieve freedom from drug addiction, the means 
for achieving this freedom and the definition of freedom may vary 
greatly between the treatment models.  The main difference in the 
models is that the abstinence-based model requires complete abstinence 
as a requirement to be in treatment and as the goal of treatment.  Harm-
reduction models can be more flexible to where the patient is in her stage 
of addiction or abuse and can be adjusted if it is not working.193  ―Harm 
reduction recognizes abstinence as an ideal outcome, but accepts 
alternatives to reduce harm.‖194  Ultimately, the goal in harm reduction is 
to ―reduce the negative effects on a patient‘s life of his or her misuse of 
substances.‖195 
There is a lot of support for the harm-reduction philosophy in the 
treatment of drug addiction.196  Benefits of the harm-reduction 
philosophy include the creation of ―a comfortable, respectful atmosphere 
in which patients can connect to the program as a whole which goes a 
long way toward solving one of the most consistent problems of 
substance abuse treatment: patient retention.‖197  Additionally, this leads 
to a strong sense of community in the program and patients feel that it is 
safe to return to the program even if they relapse because they will not 
be punished for a relapse.198 
                                                 
191 Id. at 8.  Some examples of harm-reduction strategies include the following: (1) 
―Education of the public about the dangers of drunk driving‖; (2) ―[m]ethadone 
[m]aintenance‖—other substitution therapy; (3) ―[n]eedle-exchange programs‖; and (4) 
―[t]eaching ‗alcoholics‘ to drink socially or in moderation.‖  ERICKSON, supra note 151, at 
161–62 (emphasis omitted). 
192 Roy Futterman, Maria Lorente & Susan Silverman, Integrating Harm Reduction and 
Abstinence-Based Substance Abuse Treatment in the Public Sector, 25 SUBSTANCE ABUSE 3, 3 
(2004) (footnotes omitted). 
193 Zelvin & Davis, supra note 189, at 125.  Harm reduction allows a patient to start where 
a person is—even if they are not ready to give up drug use.  Id. 
194 Id. at 124. 
195 Futterman, Lorente & Silverman, supra note 192, at 3. 
196 Id.  Harm reduction as a treatment for substance abuse ―has been one of the most 
fruitful developments in the theory and technique of substance abuse treatment, emerging 
from the integration of the formerly disconnected world of psychology along with the 
related techniques of relapse prevention and motivational interviewing.‖  Id. (footnotes 
omitted). 
197 Id. at 5. 
198 Id. at 6. 
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In the context of coerced treatment, harm-reduction models seem to 
create a greater likelihood of success than abstinence programs.  
―Mandated patients who arrive [in a harm-reduction program] initially 
with predominately external reasons to be in treatment respond well to 
the relaxed but structured attitude of harm reduction treatment.‖199  One 
of the reasons that this may be the case is that harm reduction includes 
motivational interviewing as a part of the treatment program.  
Motivational interviewing may identify internal motivators for ending 
substance use, which helps mandated patients become more invested in 
the treatment.200  Greater investment in harm-reduction programs may 
also result from the fact that ―[h]arm reduction . . . [is] a ‗bottom-up‘ 
approach based on addict advocacy rather than a ‗top-down‘ policy 
promoted by drug-policy makers.‖201 
The harm-reduction model might be more easily adopted 
internationally than in the United States.  This may be due to the fact that 
other countries have adopted a more accepting view of what constitutes 
a drug user. 
Instead of a strung-out, hung-over, untrustworthy, in 
denial, incapable of making decisions type of individual, 
they found individuals with a capacity to educate others 
and be educated, to form organizations, to manage 
funding, to represent their community, to serve on 
governmental consultative committees, and employable 
in a variety of roles while actively using drugs.202 
This redefinition of the drug user exemplifies the basic tenets of 
compassionate pragmatism that form the basis for the harm-reduction 
model, as opposed to holding drug users up to a moralistic ideal.203  
Finally, there is also some statistical evidence that harm-reduction 
treatment models are over seventy percent more effective than treatment 
based on abstinence alone.204 
                                                 
199 Id. 
200 Id. at 6–7. 
201 Zelvin & Davis, supra note 189, at 124. 
202 Id. at 125.  Countries such as England, Switzerland, The Netherlands, Canada, 
Australia, and New Zealand have found the benefits of grass-roots involvement in drug 
rehabilitation, including a redefining of the way a drug user is perceived.  Id. 
203 Id. 
204 See Anna E. Saxman, The President’s Column, 30 VT. BAR J. 3 (Summer 2004). 
―Information from the Commissioner of Health, Paul Jarris, demonstrated that medically 
assisted treatment effectiveness ranges between 85 and 90 percent; by comparison, 
treatment based on abstinence is only 15 percent effective.‖ 
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E. Integration of Abstinence and Harm-Reduction Models 
A harm-reduction strategy may seem to be antithetical to abstinence-
based programs.205  However, harm-reduction strategies can co-exist 
with abstinence models.206  Not only that, but ―mixed-modality 
programs have shown promise in bettering outcomes.‖207  Given these 
reasons, a comprehensive approach seems the most likely to achieve 
success.208 
In fact, some integrated models do exist.  In these programs, 
substance use may be allowed during treatment, while complete 
abstinence remains the ultimate goal.209  For example, under a treatment 
model that includes methadone therapy, the user will eventually 
stabilize and be able to function normally.210  However, some users will 
continue to be methadone dependent and therefore, not technically drug 
free.211  While the goal is to wean the user from all drug use, including 
methadone, the use of methadone will not be a bar to the patient‘s 
successful completion of a treatment program.  In these mixed-modality 
models, it is important to remember that although abstinence is one goal 
for the treatment of drug abusers, another key goal is to ―produce law-
abiding individuals who maintain control over their behavior.‖212 
V.  CONCLUSION:  WHAT‘S NEXT FOR THE UNITED STATES? 
To begin this discussion, it should be emphasized that drug courts in 
the United States were developed because the traditional court models 
were overloaded with cases involving drug offenders; thus, an 
alternative model was necessary to deal with this problem.  The drug 
court model has been successful at providing an alternative means for 
dealing with drug related cases.  In the United States and internationally, 
drug courts seem to increase the retention of drug abusers in treatment 
and reduce drug use and criminal behavior while abusers are in 
                                                 
205 ERICKSON, supra note 151, at 161. 
206 MARGOLIS & ZWEBEN, supra note 155, at 8. 
207 M. Douglas Anglin & Yih-Ing Hser, Treatment of Drug Abuse, 13 CRIME & JUST. 393, 395 
(1990). 
208 Barry Stimmel, From Addiction to Abstinence:  Maximizing the Chances of Success, 47 FAM. 
CT. REV. 265, 272 (2009). 
209 Futterman, Lorente & Silverman, supra note 192, at 4 (examining a program at the 
Growth and Recovery Program in North Central Bronx Hospital and Jacobi Medical Center 
in New York City). 
210 MARGOLIS & ZWEBEN, supra note 155, at 137–38. 
211 See id. at 137 (explaining that a long-term dose of methadone is substituted for short-
term illicit drug use). 
212 Hora & Stalcup, supra note 1, at 733. 
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treatment.213  ―The connection between drug abuse and crime is well 
known.‖214  When drug abuse goes untreated, offenders are more likely 
to relapse to drug abuse and return to criminal behavior.215  
Furthermore, basic tenets of drug treatment suggest that rewarding 
substance abusers for positive behavior is more effective than submitting 
substance abusers to punishment for negative behavior.216  Finally, 
―[d]rug abuse treatment is cost effective in reducing drug use and 
bringing about associated healthcare, crime, and incarceration cost 
savings.‖217 
On the basis of these foundational principles, drug courts seem to be 
a program worth continuing in the future.  However, the system of drug 
courts in the United States could take a few lessons from the 
international models and from the lessons learned by professionals in the 
field of drug treatment. 
First, drug courts in the United States should not be as quick to form 
as they have been over the past two decades.  Several countries, 
particularly Canada and the United Kingdom, have found success when 
opening drug courts by using a series of dedicated drug courts as pilot 
programs.  These programs tested various aspects of a potential drug 
court program in a limited area before expanding on a broader level.  
The result of this careful and pragmatic implementation is that each new 
drug court could learn from the previous courts.  The dedicated drug 
court could more effectively serve the population in the geographic area 
where it was situated, determine the areas (both geographically and in 
terms of treatment and training) of greatest need, and determine the 
types of participants that were likely to be served.  This planning aided 
in the acquisition of the proper training, accommodations, and resources 
to implement the court once it was established.  One thing that we can 
learn from the United Kingdom‘s observations of the dedicated drug 
courts pilot is that ―[d]iversion from criminal justice into treatment 
requires effective multidisciplinary and inter-agency working, but this 
was a weak spot in treatment provision.‖218 
                                                 
213 See Sindelar & Fiellin, supra note 173, at 260; see also Marlowe, supra note 32, at 7 (―The 
evidence is clear that drug courts can increase clients‘ exposure to treatment.‖). 
214 NATIONAL INSTITUTE ON DRUG ABUSE, U.S. DEP‘T OF HEALTH & HUM. SERVS., PUB. NO. 
06–5316, PRINCIPLES OF DRUG ABUSE TREATMENT FOR CRIMINAL JUSTICE POPULATIONS:  A 
RESEARCH-BASED GUIDE 12 (2006) (emphasis omitted). 
215 Id. at 13. 
216 Id. at 21. 
217 Id. at 26. 
218 Mary McMurran, What Works in Substance Misuse Treatments for Offenders?, 17 CRIM. 
BEHAVIOUR & MENTAL HEALTH 225, 229 (2007). Reconviction was significantly less likely 
amongst those who completed their diversion programs (fifty-three percent) than those 
whose orders were revoked.  Id. 
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While the number of drug courts that are currently operating in the 
United States is impressive, the quality may be improved if we allocated 
resources to the study and observation of existing drug courts to 
determine what techniques or practices are most effective in serving the 
populations.  This may aid in the planning and development of more 
efficient and successful drug courts in the future. 
The next important change to drug courts in the United States would 
be to move toward a model of treatment that is more in line with a harm-
reduction approach.  Not only do professionals in the field of addiction 
treatment view this as a more effective model for drug treatment, but 
also it is a widely used model in drug courts internationally.  The United 
States is unlikely to adopt a pure harm-reduction model for a number of 
reasons.  The chief reason is that use of any illegal drug cannot be 
condoned by the criminal justice system.219  However, recognition that 
addiction is a disease and that it is difficult to overcome should allow the 
courts to move toward a model where abstinence is the ultimate goal 
and harm reduction is the operating model during treatment.220  
Arguably, the courts are already operating in this model.  Some drug use 
during treatment will not usually result in the participant being thrown 
out of the program.  However, the current model may impose 
punishments on those individuals who do slip up.  This negative 
enforcement is not the most effective means of treatment and would be 
removed in mixed-modality treatment program. 
Additionally, if the United States truly views drug courts as a means 
to combat the growing problem of drugs in society, it needs to use the 
approach that is most likely to result in successful treatment for a user‘s 
drug addiction.  This means that the users need to be viewed as a whole.  
All parts of the user‘s life must be considered to help bring the user back 
to a level where she functions effectively in society.  What is the value of 
success when a person abstains from drug use for a mandated period of 
time and then relapses shortly after completion of her sentence?  It 
would be more beneficial to our society to have individuals who are able 
to function and contribute, even if that means those individuals have an 
occasional drug habit that they are continuing to treat and control. 
                                                 
219 There are several arguments that the use of less dangerous drugs, such as marijuana, 
should be legalized and/or that monitored use of controlled substances could be legal; 
however, those are issues for another article. 
220 Another option is to create an alternative to drug courts, such as a coerced abstinence 
program.  Sindelar & Fiellin, supra note 173, at 260.  This program would allow ―early 
release of some drug-abusing, nonviolent prisoners to a probation program that frequently 
tests for drug abuse.‖  Id.  However, if courts revert back to this model, it would not likely 
be any more effective than the expedited drug case management system that the drug 
treatment court model rejects. 
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Another frustrating challenge is that despite its effectiveness, 
addiction medications are not frequently used to treat users within the 
criminal justice system.221  The science of addiction and medicine is a 
growing field.  More and more medications are being developed to treat 
and prevent addictions.  Although the cost may be a concern, the judicial 
system should not ignore the significant treatment options that are 
presented in a pharmacological treatment regimen. 
Although the rising costs of drug courts and the depressing state of 
the economy will continue to serve as excuses for not funding drug 
courts or for not adopting more effective methods of treatment,222 they 
should not be the stumbling blocks that bring the progress and 
development of drug courts in the United States to a halt.223  From a 
fiscal standpoint, drug courts are better than continuing to lock people 
up.224  This not only does a disservice to those who need treatment, but 
also to all those who foot the bill for the results of failure to provide this 
                                                 
221 See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 214, at 23 (―Despite evidence of 
their effectiveness, addiction medications are underutilized in the treatment of drug 
abusers within the criminal justice system.  Still, some jurisdictions have found ways to 
successfully implement medication therapy for drug abusing offenders.‖). 
222 Report Urges Expansion of Inmate Substance Abuse Treatment Programs, 15 CORRECTIONS 
PROF., no. 10, March 1, 2010.―‗States complain mightily about their rising prison costs,‘ said 
Susan E. Foster, CASA‘s vice president and director of policy research and analysis.  ‗Yet 
they continue to hemorrhage public funds that could be saved if they provided treatment 
to inmates with alcohol and other drug problems and stepped up use of drug courts and 
prosecutorial drug treatment alternative programs.‘‖  Id.  Indeed, some jurisdictions cannot 
even cling to these excuses.  In Minnesota, for example, hope is not lost despite the bleak 
economic situation facing the courts. Attorney General Eric H. Holder says that he will 
continue to find more effective ways to deal with nonviolent drug crimes, including drug 
courts.  James Podgers, Holder Speech Highlights ABAB Annual Meeting:  New Attorney 
General Says Administration Will Seek “Smart” Strategies to Address Crime, 95 A.B.A. J. 63 
(Sept. 2009).  Perhaps there are also some means of creative financing that courts can 
explore.  See Hora, Schma & Rosenthal, supra note 1, at 511–12 (describing different 
methods of funding for drug courts). 
223 There may be other challenges to drug courts in the United States and abroad.  One 
particular challenge that faces the courts is the treatment of minorities and determining if 
the current system fails in this respect.  There are mixed views on this point.  See Bowers, 
supra note 21, at 807 (discussing how minorities are more frequently terminated from drug 
courts than their white counterparts); Wright, supra note 2, at 79–80 (noting that more 
minorities are arrested for drug use than whites and pointing out the bias against 
minorities in the court sentencing structure).  If so, what does this mean for populations in 
other cultures such as the Maori in New Zealand or the Aborigine in Australia?  Is there 
room for drug courts in cultures where the structure of the court systems is varied (i.e. 
African tribal courts—there may be some potential in this area as there are a number of 
tribal courts in the United States as well as aboriginal courts in Australia)? 
224 See Jane Pribek, Wisconsin Attorney Hon. M. Joseph Donald:  Offenders Reform in New 
Drug Court, WISC. L. J., March 8, 2010; see also Hora & Stalcup, supra note 1, at 765–66 
(providing statistics on the success of drug courts). 
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treatment.  In a report issued by The National Center on Addiction and 
Substance Abuse at Columbia University, the study 
found that while 65 percent of inmates meet the medical 
criteria for substance abuse addiction, only 11 percent 
receive any treatment. Researchers concluded that if all 
inmates who needed treatment and aftercare received 
such services, the nation would break even in one year if 
a little more than 10 percent remained substance free, 
crime free and employed.225 
―Because addiction is a disease that most medical professionals agree 
cannot be overcome by self-will alone, merely incarcerating substance 
abusers or placing them on probation without treatment fails to treat the 
disease and invites the inevitability of recidivism.‖226 
After twenty years, the score is not completely settled with respect to 
drug courts in the United States.  While they have continually grown in 
number and efforts have been undertaken to help in the effective 
operation, there are significant changes that will improve the 
effectiveness of drug courts in the United States.  Taking a cue from its 
international counterparts and from the field of drug treatment, the 
United States should consider shifting its model of treatment away from 
a purely abstinence-based approach toward a harm-reduction approach.  
Additionally, following in the footsteps of several of the international 
drug courts, the United States should slow the growth of drug courts 
and spend more time evaluating and observing the operation of its drug 
courts.  Doing so will help to improve the quality of the existing drug 
courts and aid in the creation and development of drug courts in the 
future. 
                                                 
225 CORRECTIONS PROF., supra note 222. 
226 Hora & Stalcup, supra note 1, at 724. 
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